Avid Bioservices, Inc. (CDMO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

19.20

+0.29

(+1.53%)

As of 02:33PM EDT. Market open.

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Price Crosses Moving Average

View all chart patterns

Performance Outlook

Previous Close	18.91
Open	18.96
Bid	19.14 x 800
Ask	19.18 x 1300
Day's Range	18.60 - 19.31
52 Week Range	11.30 - 34.51
Volume	115,792
Avg. Volume	597,109

Market Cap	1.187B
Beta (5Y Monthly)	2.15
PE Ratio (TTM)	10.67
EPS (TTM)	1.80
Earnings Date	Sep 06, 2022 - Sep 12, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	26.67

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Undervalued

27% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CDMO

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Avid Bioservices, Inc.
Daily – Vickers Top Buyers & Sellers for 07/13/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Rating
Fair Value
Economic Moat
last monthArgus Research

All

Insider Monkey
Is Avid Bioservices (CDMO) a Worthy Investment Pick?
Laughing Water Capital, an investment management firm, published its second-quarter 2022 investor letter – a copy of which can be downloaded here. For Q2 2022 Class A interests in Laughing Water Capital returned approximately -19.4%, bringing our year-to-date returns to approximately -29.5%. The SP500 and R2000 returned -16.1% and -17.2% for the quarter, bringing year-to-date […]
- CynergisTek (CTEK), An Expensive Portfolio Management Lesson For Long Cast Advisers
  Insider Monkey
- Mayar Capital’s Largest Holding: Johnson & Johnson (JNJ)
  Insider Monkey
Insider Monkey
Is Avid Bioservices (CDMO) a Great Buy?
Investment management company Laughing Water Capital released its second quarter investor letter 2022, a copy of the same can be downloaded here. In the second quarter, the fund returned -19.4%, which brings the year-to-date return to -29.5%. The letter discussed the reasons for the underperformance of its portfolios. S&P 500 & Russell 2000 also underperformed in […]
Benzinga
Read How Avid Bioservices Fared In Q4
View more earnings on CDMOSee more from BenzingaNovartis' Tislelizumab Extends Overall Survival In Late-Stage Esophageal Cancer StudyNovartis Resumes Production, Delivery Of Radioligand Therapy MedicinesDon't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.